Dublin Medtech start-up wins €2.7m in funding

Oncomark’s diagnostic tech helps breast cancer patients avoid unnecessary chemotherapy

Mairin Rafferty, chief operations officer of Oncomark, with chief executive Desmond O'Leary and chief science officer William Gallagher

Company: OncoMark

Done deal:€2.7m funding

The clincher: “This award will enable us to accelerate the OncoMasTR test from the laboratory to the clinic, as well as creating employment opportunities.” - Des O’Leary, chief executive, OncoMark

Diagnostic technology that could help breast cancer patients avoid unnecessary post-operative chemotherapy has earned a Dublin start-up €2.7 million in funding.

OncoMark is developing a test that uses cancer biomarkers to determine whether or not early-stage breast cancer ...